Differential activation of nuclear factor-κB by tumour necrosis factor receptor subtypes.: TNFR1 predominates whereas TNFR2 activates transcription poorly

被引:75
作者
McFarlane, SM
Pashmi, G
Connell, MC
Littlejohn, AF
Tucker, SJ
Vandenabeele, P
MacEwan, DJ [1 ]
机构
[1] Univ Aberdeen, Dept Biomed Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland
[2] State Univ Ghent VIB, Dept Mol Biol, B-9000 Ghent, Belgium
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
cytokine; receptor; subtype; signal transduction; kinase; tumour;
D O I
10.1016/S0014-5793(02)02450-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumour necrosis factor-alpha (TNF-alpha) signals though two receptors, TNFR1 and TNFR2. TNFR1 has a role in cytotoxicity, whereas TNFR2 regulates death responses or proliferation. TNF activates pro-inflammatory transcription factor nuclear factor-kappaB (NF-kappaB) by uncertain signalling mechanisms. Here we report the contribution of each TNFR towards the NF-kappaB activation processes. In human cells expressing endogenous or exogenous TNFR2, in addition to TNFR1, we found both TNFRs capable of activating NF-kappaB as measured by IkappaBalpha (inhibitor of NF-kappaB) degradation, electrophorefic mobility shift assay and NF-kappaB gene reporter assays. TNFR2 activation did not degrade IkappaBbeta. However, TNF-effects on NF-kappaB activation occurred predominantly through TNFR1, with TNFR2 activating the transcription factor poorly. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 47 条
[1]  
Aggarwal BB, 2000, ANN RHEUM DIS, V59, P6
[2]  
Amrani Y, 1999, J IMMUNOL, V163, P2128
[3]   Tumor necrosis factor-α mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression [J].
Baxter, GT ;
Kuo, RC ;
Jupp, OJ ;
Vandenabeele, P ;
MacEwan, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9539-9547
[4]   Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-κB activation [J].
Brink, R ;
Lodish, HF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (07) :4129-4134
[5]   GENERATION AND BIOLOGICAL CHARACTERIZATION OF MEMBRANE-BOUND, UNCLEAVABLE MURINE TUMOR-NECROSIS-FACTOR [J].
DECOSTER, E ;
VANHAESEBROECK, B ;
VANDENABEELE, P ;
GROOTEN, J ;
FIERS, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) :18473-18478
[6]   Hormonal regulation of the NF-κB signaling pathway [J].
Delfino, F ;
Walker, WH .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 157 (1-2) :1-9
[7]   A cytokine-responsive I kappa B kinase that activates the transcription factor NF-kappa B [J].
DiDonato, JA ;
Hayakawa, M ;
Rothwarf, DM ;
Zandi, E ;
Karin, M .
NATURE, 1997, 388 (6642) :548-554
[8]  
DU W, 1998, CELL, V4, P887
[9]   Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30:: a role for TNF-R1 activation by endogenous membrane-anchored TNF [J].
Grell, M ;
Zimmermann, G ;
Gottfried, E ;
Chen, CM ;
Grünwald, U ;
Huang, DCS ;
Lee, YHW ;
Dürkop, H ;
Engelmann, H ;
Scheurich, P ;
Wajant, H ;
Strasser, A .
EMBO JOURNAL, 1999, 18 (11) :3034-3043
[10]   THE TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR IS THE PRIME ACTIVATING LIGAND OF THE 80 KDA TUMOR-NECROSIS-FACTOR RECEPTOR [J].
GRELL, M ;
DOUNI, E ;
WAJANT, H ;
LOHDEN, M ;
CLAUSS, M ;
MAXEINER, B ;
GEORGOPOULOS, S ;
LESSLAUER, W ;
KOLLIAS, G ;
PFIZENMAIER, K ;
SCHEURICH, P .
CELL, 1995, 83 (05) :793-802